Metas & Vision Competitors

Quantum Vision provides quality, business-aligned technology solutions to help our clients grow and prosper in an ever-evolving marketplace. We leverage enterprise experience and industry expertise to deliver a range of IT solutions to clients operating in different industries. From software application and product development, to application management, to systems and technology integration services, Quantum Vision helps our clients respond to new challenges and opportunities with proven, practical strategy. Our flexible approaches are driven by our core principles: we value lasting relationships that foster mutual success, and are committed to empowering our clients through innovation and integrity. We have been recognized on the Inc. 500/Inc. 5000 lists of fastest-growing private companies in the United States for three years in a row, and continue to build our reputation as a business-focused IT solutions provider.

VISITECH® is the leading imaging solution partner to various manufacturing industries from chips manufacturing to bioprinting. With a strong heritage and in close proximity to Texas Instruments in its Texas location, the company is at the vanguard of DLP technology, always serving as an imaging partner to customers who develop cutting edge manufacturing technologies. Our experienced engineering team has made many DLP related products in various applications during the past 17 years. Our DLP products include configurations from the complete range of Texas Instruments’ DLP chip sets for industrial applications. In addition, VISITECH, has particular design experience within imaging system design, real time systems, high speed image processing, optical design, thermal and mechanical design and smart light sources, including advanced LED controllers.

NovaVision® provides vision solutions targeted at this substantial and largely un-addressed group of people who have lost their sight as a result of Stroke, Traumatic Brain Injury (TBI) or other neurological brain damage. NovaVision has a family of therapies that both restore and help compensate and re-train for vision loss. NovaVision’s Vision Restoration Therapy (VRT) is a therapy specifically developed to help restore lost vision resulting from Stroke or TBI, and is carried out in the comfort of a patient’s home. NovaVision’s VRT is the only FDA Cleared (510k) therapy targeted at the restoration of this type of vision loss. VRT is underpinned by 15 years of research and over 20 studies, including a 302 patient study in which notable improvements were seen in 70% of the patients. NovaVision’s NeuroEyeCoach is a compensation technique based on several decades of scientific research that is designed to teach patients to direct their gaze towards the affected area bringing previously undetected objects into sight. The patient can complete the therapy in the comfort of their own home on their own computer, in 2-4 weeks. NovaVision has put together a world class Scientific Advisory Board of distinguished professors and physicians. • Arash Sahraie (CSO), PhD - Professor and Chair in Vision Sciences at the University of Aberdeen • Alvaro Pascual-Leone, MD, PhD - Professor of Neurology at Harvard Medical School and Director of Research at the Cognitive Neurology Unit at Beth Israel Deaconess Medical Center • Joseph Zihl, PhD - Professor of Neuropsychology at the Department of Psychology, University of Munich, and Head of the Neuropsychology Research Group at the Max Planck Institute of Psychiatry • Jose Romano, MD - Chief of Stroke Division and Professor of Neurology at the University of Miami Miller School of Medicine • Jason S. Barton, MD, PhD - Professor of Neurology, Ophthalmology and Visual Sciences, University of British Columbia